Document Detail


The Challenge of Antiplatelet Therapy in Patients with Atrial Fibrillation and Heart Failure.
MedLine Citation:
PMID:  23208014     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Antiplatelet therapy is the cornerstone of secondary prevention in cardiovascular disease. This review focuses on the role of antiplatelet therapy in atrial fibrillation (AF) and heart failure (HF). Aspirin has a limited role in stroke prevention among most patients with AF, being of limited efficacy and not any safer than warfarin, especially in the elderly. For HF patients with AF, cardioembolism is a major cause of stroke, and antiplatelet alone would be insufficient thromboprophylaxis. Aspirin plus clopidogrel rather than aspirin alone is preferred for those AF patients who have refused any form of oral anticoagulation. For AF patients undergoing percutaneous coronary intervention, triple antithrombotic therapy (aspirin, clopidogrel, and warfarin) is recommended for the initial period (1-6 months) based on the stent type, followed by vitamin K antagonists (VKA) and clopidogrel or, alternatively VKA and aspirin for up to 12 months. In AF patients with stable vascular disease, VKA monotherapy would suffice.
Authors:
Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Related Documents :
23790594 - Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.
4044994 - Derivation of a bioclinical prognostic index in severe head injury.
24250954 - The relationship between serum nt- pro-bnp levels and prognosis in patients with systol...
2769274 - Xanthochromia after subarachnoid haemorrhage needs no revisitation.
23713804 - Primary sclerosing cholangitis is associated with autoreactive iga antibodies against b...
6896174 - The involvement of the pentose shunt in thyroid metabolism after stimulation with tsh o...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Journal of cardiovascular translational research     Volume:  -     ISSN:  1937-5395     ISO Abbreviation:  J Cardiovasc Transl Res     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101468585     Medline TA:  J Cardiovasc Transl Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
Next Document:  Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary art...